Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=nih_________::3c325b612a929e7952eba3dfb8876f1a&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's Disease

assignment_turned_inproject01 Mar 2020(Started)-28 Feb 2025(Ended)Closed

Funder: National Institutes of HealthProject code: 7R01NS114130-05

Funded under: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE Funder Contribution: 181,309 USD

Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's Disease

- Summary
- DMPs

Partners

YALE UNIVERSITY

Data Management Plans

Start a new DMP in Argos

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=nih_________::3c325b612a929e7952eba3dfb8876f1a&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's Disease

Targeting Kv1.3 potassium channels for neuro-immunomodulation in Alzheimer's Disease

Loading